Ganymede
AcquiredConnect your instruments to power clean data, analysis, and AI
New York, United States · Founded 2022
- Headquarters
- New York, New York
- Employees
- 11–50
- Founded
- 2022
- Business Model
- B2B
- Website
- ganymede.bio
- Last Round
- Series ADec 2022
- Rounds
- 2
About
Ganymede is a cloud data platform for life science labs that connects instruments, ELNs, LIMS, and applications to standardize and unify wet and dry lab data. Its modular Lab-as-Code platform automates repetitive analysis workflows, enables AI integration, and supports small molecules, biologics, cell and gene therapies, and synthetic biology. Clients include diagnostics, bioprocess, and analytical chemistry teams.
Summary
Ganymede is a Life Sciences company based in New York, United States, founded in 2022. Its most recent funding was a Series A round in Dec 2022. Investors include Caffeinated Capital, BoxGroup and SciFi VC.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2022
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Databricks is the pioneer of the data lakehouse, a unified platform for data science, machine lea...
AI-powered platform designed for immigration law firms
Food and facilities management services
Visma is a European provider of mission-critical enterprise resource planning software and servic...
For more than 30 years, BMC has helped thousands of companies around the world master IT complexi...